Old ways of doing business may soon stop working, but there are also new opportunities to adapt
In Australia , Melanotan II is classified as a Schedule 4 prescription-only medicine by the Therapeutic Goods Administration (TGA)
1 These data highlight the exciting potential of cagrilintide to offer an alternative approach for people to lose weight, achieve health-related outcomes and manage their obesity, including a favourable tolerability profile, said lead investigator Timothy Garvey, MD, professor of medicine and director of the Diabetes Research Center at the University of Alabama at Birmingham
In fact, these same medications are now being investigated for some serious and potentially permanent side effects, including vision loss
Asian journal of andrology, 3 (4), 301-303